Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes -: Early Treatment Diabetic Retinopathy Study Report no. 27

被引:136
作者
Cusick, M
Meleth, AD
Agrón, E
Fisher, MR
Reed, GF
Knatterud, GL
Barton, FB
Davis, MD
Ferris, FL
Chew, EY
机构
[1] NEI, NIH, Bethesda, MD 20892 USA
[2] NIH, Howard Hughes Med Inst, Bethesda, MD 20892 USA
[3] Univ Wisconsin, Dept Ophthalmol, Madison, WI USA
[4] Maryland Med Res Inst, Baltimore, MD USA
[5] EMMES, Rockville, MD USA
关键词
D O I
10.2337/diacare.28.3.617
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Diabetes is a leading cause of morbidity and mortality. The purpose of this study is to assess the associations between diabetes complications and mortality in the Early Treatment Diabetic Retinopathy Study (ETDRS). RESEARCH DESIGN AND METHODS - We examined demographic, clinical, and laboratory characteristics of the 3,711 subjects enrolled in the ETDRS, a randomized controlled clinical trial designed to evaluate the role of laser photocoagulation and aspirin therapy for diabetic retinopathy. The outcome assessed was all-cause mortality. Multivariable Cox proportional hazards regression was used to assess associations between diabetes complications and mortality for type 1 and type 2 diabetes separately. RESULTS - The 5-year estimates of all-cause mortality were 5.5 and 18.9% for patients with type 1 and type 2 diabetes, respectively. In patients with type 1 diabetes, amputation (hazard ratio [HR] 5.08 [95% CI 2.06-12.54]) and poor visual acuity (1.74 [1.10-2.75]) remained significantly associated with mortality, after adjusting for other diabetes complication's and baseline characteristics. In patients with type 2 diabetes, macrovascular disease and worsening levels of nephropathy, neuropathy, retinopathy, and visual acuity are associated with progressively increasing risks of mortality, after controlling for other baseline risk factors. CONCLUSIONS - Amputation is the strongest predictor for mortality in. patients. with type 1 diabetes. All complications independently predict mortality in patients with type 2 diabetes. There is an increased risk for mortality as the degree of each complication worsens. Additional studies are needed to investigate the effectiveness of tertiary prevention to decrease mortality in these patients.
引用
收藏
页码:617 / 625
页数:9
相关论文
共 73 条
  • [1] EFFECT OF DIABETES-MELLITUS ON SHORT-TERM AND LONG-TERM MORTALITY-RATES OF PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - A STATEWIDE STUDY
    ABBUD, ZA
    SHINDLER, DM
    WILSON, AC
    KOSTIS, JB
    [J]. AMERICAN HEART JOURNAL, 1995, 130 (01) : 51 - 58
  • [2] Dipstick proteinuria: Can it guide hypertension management?
    Agarwal, R
    Panesar, A
    Lewis, RR
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (06) : 1190 - 1195
  • [3] [Anonymous], 1991, OPHTHALMOLOGY, V98, P741
  • [4] [Anonymous], 1991, Ophthalmology, V98, P786
  • [5] ARIAS E, 2001, NATL VITAL STAT REPO, V52
  • [6] Ten-year survival after acute myocardial infarction: Comparison of patients with and without diabetes
    Behar, S
    Boyko, V
    ReicherReiss, H
    Goldbourt, U
    [J]. AMERICAN HEART JOURNAL, 1997, 133 (03) : 290 - 296
  • [7] FREQUENCY OF RECORDING OF DIABETES ON UNITED-STATES DEATH CERTIFICATES - ANALYSIS OF THE 1986 NATIONAL MORTALITY FOLLOWBACK SURVEY
    BILD, DE
    STEVENSON, JM
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (03) : 275 - 281
  • [8] Boyko EJ, 1996, DIABETIC MED, V13, P967, DOI 10.1002/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.3.CO
  • [9] 2-B
  • [10] Projection of diabetes burden through 2050 - Impact of changing demography and disease prevalence in the US
    Boyle, JP
    Honeycutt, AA
    Narayan, KMV
    Hoerger, TJ
    Geiss, LS
    Chen, H
    Thompson, TJ
    [J]. DIABETES CARE, 2001, 24 (11) : 1936 - 1940